Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer's disease in the rat model.

[1]  A. Daryani,et al.  Controversial Effects of Diverse Types of Toxoplasma gondii on the Anxiety-Related Behavior and Cognitive Impairments in the Animal Model of Alzheimer's Disease , 2022, Iranian Journal of Psychiatry and Behavioral Sciences.

[2]  B. Brown,et al.  Examining the Relationship between Toxoplasma gondii and Seropositivity and Serointensity and Depression in Adults from the United Kingdom and the United States: A Cross-Sectional Study , 2021, Pathogens.

[3]  A. Daryani,et al.  Genetic diversity of Toxoplasma gondii isolates from rodents in the world: A systematic review. , 2021, Transboundary and emerging diseases.

[4]  E. Shin,et al.  Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in Toxoplasma gondii-Infected Alzheimer’s Disease Model Mice , 2021, International journal of molecular sciences.

[5]  Xiaoli Zhang,et al.  From inflammatory reactions to neurotransmitter changes: Implications for understanding the neurobehavioral changes in mice chronically infected with Toxoplasma gondii , 2019, Behavioural Brain Research.

[6]  J. Blackwell,et al.  Epigenetic dysregulation of host gene expression in Toxoplasma infection with specific reference to dopamine and amyloid pathways. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  N. Mohtarrudin,et al.  Toxoplasma Gondii Stimulates The Behavioural Changes of Rodents: Updated Evidence , 2018 .

[8]  E. Severance,et al.  Chronic Toxoplasma gondii Infection Induces Anti-N-Methyl-d-Aspartate Receptor Autoantibodies and Associated Behavioral Changes and Neuropathology , 2018, Infection and Immunity.

[9]  B. Fux,et al.  Toxoplasma gondii: isolation, biological and molecular characterisation of samples from free-range Gallus gallus domesticus from countryside Southeast Brazil. , 2018, Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria.

[10]  T. A. Cleland,et al.  Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL/6 mice , 2018, Journal of Neuroinflammation.

[11]  A. Koshy,et al.  Dissecting Amyloid Beta Deposition Using Distinct Strains of the Neurotropic Parasite Toxoplasma gondii as a Novel Tool , 2017, ASN neuro.

[12]  G. Gigli,et al.  Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients , 2017, Neurodegenerative Diseases.

[13]  G. McConkey,et al.  Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection , 2017, Pathogens.

[14]  V. Sheibani,et al.  Acetylcholinesterase Inhibitor Improves Learning and Memory Impairment Induced by Toxoplasma gondii Infection , 2016, Iranian journal of parasitology.

[15]  S. Karanja,et al.  Detection of Natural Toxoplasma gondii Infection in Chicken in Thika Region of Kenya Using Nested Polymerase Chain Reaction , 2016, BioMed research international.

[16]  A. Keyhani,et al.  Toxoplasma gondii Infection Potentiates Cognitive Impairments of Alzheimer's Disease in the BALB/c Mice , 2016, Journal of Parasitology.

[17]  M. Birjandi,et al.  Seroprevalence of Toxoplasma gondii Infection in Patients with Alzheimer’s Disease , 2016 .

[18]  H. Sadeghi-Bazargani,et al.  Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? , 2016, Parasitology Research.

[19]  J. Kauwe,et al.  Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease , 2016, Alzheimer disease and associated disorders.

[20]  A. Kaddoumi,et al.  Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β. , 2016, Journal of systems and integrative neuroscience.

[21]  Jeffrey S. Buguliskis,et al.  Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes , 2016, Acta Neuropathologica Communications.

[22]  D. Hill,et al.  A Systematic Meta-Analysis of Toxoplasma gondii Prevalence in Food Animals in the United States. , 2016, Foodborne pathogens and disease.

[23]  D. Hill,et al.  Qualitative Assessment for Toxoplasma gondii Exposure Risk Associated with Meat Products in the United States. , 2015, Journal of food protection.

[24]  D. Lindsay,et al.  Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System , 2015, mBio.

[25]  Quan Liu,et al.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii , 2015, Parasites & Vectors.

[26]  F. Bruschi,et al.  Neurobiological studies on the relationship between toxoplasmosis and neuropsychiatric diseases , 2015, Journal of the Neurological Sciences.

[27]  D. Schlüter,et al.  Toxoplasma gondii‐induced neuronal alterations , 2015, Parasite immunology.

[28]  Jean-Philippe Michaud,et al.  Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer’s Disease-Related Pathology , 2015, Neuron.

[29]  M. Guillot-Sestier,et al.  Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.

[30]  Nathan D. Price,et al.  IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.

[31]  M. Falkenstein,et al.  Toxoplasma gondii impairs memory in infected seniors , 2014, Brain, Behavior, and Immunity.

[32]  J. Prandota.  Possible Link Between Toxoplasma Gondii and the Anosmia Associated With Neurodegenerative Diseases , 2014, American journal of Alzheimer's disease and other dementias.

[33]  Xing-Quan Zhu,et al.  Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping , 2013, Parasitology.

[34]  A. Lymbery,et al.  Adaptive host manipulation by Toxoplasma gondii: fact or fiction? , 2013, Trends in parasitology.

[35]  F. LaFerla,et al.  Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model , 2013, The Journal of Neuroscience.

[36]  M. Pletnikov,et al.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. , 2012, Schizophrenia bulletin.

[37]  H. Scheich,et al.  Toxoplasma gondii Actively Inhibits Neuronal Function in Chronically Infected Mice , 2012, PloS one.

[38]  Y. Suh,et al.  Toxoplasma gondii Infection in the Brain Inhibits Neuronal Degeneration and Learning and Memory Impairments in a Murine Model of Alzheimer's Disease , 2012, PloS one.

[39]  M. R. Amendoeira,et al.  Occurrence of infection with Toxoplasma gondii and factors associated with transmission in broiler chickens and laying hens in different raising systems , 2012 .

[40]  C. G. Moore,et al.  Toxoplasma gondii in circumpolar people and wildlife. , 2012, Vector borne and zoonotic diseases.

[41]  M. O’Banion,et al.  Chronic IL-1β-Mediated Neuroinflammation Mitigates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease without Inducing Overt Neurodegeneration , 2011, Journal of Neuroimmune Pharmacology.

[42]  J. Flegr,et al.  The Distribution of Toxoplasma gondii Cysts in the Brain of a Mouse with Latent Toxoplasmosis: Implications for the Behavioral Manipulation Hypothesis , 2011, PloS one.

[43]  J Zhang,et al.  The −1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: A meta-analysis , 2011, Journal of the Neurological Sciences.

[44]  M. Yaman,et al.  Could Toxoplasma gondii Have any Role in Alzheimer Disease? , 2011, Alzheimer disease and associated disorders.

[45]  H. Langoni,et al.  Toxoplasma gondii: host–parasite interaction and behavior manipulation , 2009, Parasitology Research.

[46]  Colin L Masters,et al.  Aβ aggregation and possible implications in Alzheimer's disease pathogenesis , 2009, Journal of cellular and molecular medicine.

[47]  J. Kalil,et al.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly , 2008, Clinical ophthalmology.

[48]  Rena Li,et al.  Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice , 2007, The Journal of Cell Biology.

[49]  J. Webster.  The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. , 2007, Schizophrenia bulletin.

[50]  J. Flegr.  Effects of toxoplasma on human behavior. , 2007, Schizophrenia bulletin.

[51]  Brian J. Bacskai,et al.  Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease , 2006, Neurobiology of Disease.

[52]  W. de Souza,et al.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia. , 2005, The American journal of pathology.

[53]  H. Chiu,et al.  The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease , 2005, Neurobiology of Aging.

[54]  M. Skrzypczak,et al.  Recent trends in molecular diagnostics for Toxoplasma gondii infections. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[55]  J. Montoya,et al.  Toxoplasmosis , 2004, The Lancet.

[56]  M. Dardé.  Genetic analysis of the diversity in Toxoplasma gondii. , 2004, Annali dell'Istituto superiore di sanita.

[57]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[58]  C. Franceschi,et al.  Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease , 2003, Genes and Immunity.

[59]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[60]  A. Weverling-Rijnsburger,et al.  Patients with Alzheimer's disease display a pro-inflammatory phenotype , 2001, Experimental Gerontology.

[61]  L. David Sibley,et al.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.

[62]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.